Fleet Phospho Soda (Oral Sodium Phosphate) Linked to Severe Kidney Disease

Fleet Phospho Soda is a brand of over-the-counter bowel cleanser that is commonly used in high doses as a laxative to treat constipation or to prepare for colonoscopy and other surgeries. Use of the product as a laxative has been shown to cause acute phosphate nephropathy, a rare but severe form of kidney disease. A build up of calcium-phosphate crystals in the kidneys caused by taking the product can result in permanent renal impairment.

The makers of Fleet Phospho Soda have for years promoted using the bowel cleansing product in double-doses as a laxative without a prescription of doctor supervision. However, the high doses can cause permanent kidney damage, particularly in the elderly, young children, and people with kidney failure. Fleet Phospho-soda and Fleet Phospho-soda EZ-Prep Bowel were recalled in December 2008 due to concerns about the link to acute phosphate nephropathy.

If you or a loved one has taken Fleet Phospho Soda products in high doses and developed the form of kidney damage called acute phosphate nephropathy, you may be entitled to financial compensation. At Mark & Associates, P.C. our aggressive, experienced personal injury attorneys are dedicated to helping people who are injured by Fleet Phospho Soda and other brands of oral sodium phosphate bowel cleansing products receive the financial compensation they deserve. To schedule a free, confidential legal consultation, contact us today by calling 1-866-50-RIGHTS (1-866-507-4448) or completing the case inquiry form on this page.

FDA Issues Warning, Fleet Phospho Soda Recalled

In December 2008, Fleet Phospho Soda was recalled after the Food and Drug Administration issued a safety warning about the risks of developing acute phosphate nephropathy from high-dose use of over-the-counter oral sodium phosphate bowel cleansing products.

The FDA advised users not to take double doses of bowel cleansing drugs as laxatives if they are:

  • Over age 55 or under age 18
  • Suffering from dehydration, heart failure, kidney disease, acute colitis, or delayed bowel emptying
  • Taking medicines that affect kidney function, including diuretics, certain arthritis medications, and medications which lower blood pressure
  • Diagnosed with heart or kidney failure
  • Taking other laxative products containing sodium phosphate

Other Common Side Effects

In addition to causing acute phosphate nephropathy, high doses of Fleet Phospho Soda have been shown to cause the following side effects:

  • Dehydration
  • Vomiting
  • Dizziness
  • Less frequent urination
  • Difficultly drinking liquids
  • Abdominal pain or bloating
  • Nausea
  • Headache

Free Legal Consultation

If you or a loved one has taken Fleet Phospho Soda or another over-the-counter brand of oral sodium phosphate product and developed the form of kidney disease called acute phosphate nephropathy, you may have important legal rights. You and your family may be eligible to receive financial compensation from the maker of the bowel cleaning solutions or another responsible party. At Mark & Associates, P.C., our experienced personal injury attorneys will evaluate your situation and advise you of all your legal rights. Contact Mark & Associates, P.C. today for a free, no-obligation review of your possible Fleet Phospho Soda and kidney damage case by calling 1-866-50-RIGHTS (1-866-507-4448) or completing the form on this page.

Other News

  • Avandia to be removed from Pharmacies

    Avandia the widely prescribed type 2 diabetes drug has been linked to increased cardiovascular risks and the debate has carried on for nearly four years about whether or not the drug should be taken off the market, according to a recent WebMD news report. The FDA issued a safety alert about a possible association between Avandia and increased cardiovascular risks back in 2007. Starting November 2011, the type 2 diabetes drugs Avandia, Avandamet, and Avandaryl will no longer be available [...]

    Read more →

  • Metal Hip Manufactures Asked to Provide Patient Data

    Not too long ago, DePuy Orthopaedics, a division of Johnson & Johnson, recalled two popular hip replacements systems the ASR Hip Resurfacing System and the ASR XL Acetabular System. Depuy said the products were recalled because a high percentage of patients required revision surgery after experiencing pain. Depuy said that it sold 93,000 of these systems before they decided to stop selling them last year. Additionally, dozens of other patients who have had other hip replacements from other manufacturers, such [...]

    Read more →

  • Jury Orders Allergan to Pay $212 Million in Botox Case

    A Virginia man who claimed that injections of the wrinkle-diminishing Botox left him with brain damage has been awarded $212 million by manufacturer Allergan Inc. Douglas Ray Jr. said he was receiving the injections to relieve a hand tremor and writer’s cramp, a report in the Richmond-Times Dispatch said. Ray said that that Allergan failed to warn him that injections could trigger an autoimmune response leading to brain damage. Botox is a purified form of the poison botulinum and is [...]

    Read more →

  • Drug Manufacturers to Discontinue Infant Drops of Key Medicine

    According to a recently released Associated Press news report, Johnson & Johnson and other drug makers of cold and fever medications said that they will discontinue infant drops of medicines containing acetaminophen in an effort to avoid confusion that can lead to dangerous overdoses. The industry association for over-the-counter medicine companies said its members will begin phasing out the liquid drops later this year. After the transition is complete, companies will only sell a single formula for all children under [...]

    Read more →

  • Bisphosphonates Linked to Bone Fractures: Study

    Findings from a new Swedish study reveal that osteoporosis drugs known as bisphosphonates increase the risk of getting unusual thigh bone fractures, as experts have suspected, according to a recent WebMD news article. But these fractures are infrequent and the risk is small the study shows. When correctly prescribed, the overall benefit of the drugs preventing all types of fractures outweighs the risk of getting the unusual fractures, says study researcher Per Aspenberg, MD, PhD, a professor of orthopaedic surgery [...]

    Read more →

  • Babies Heart Defect linked to Crude Oil Chemical Exposure

    According to an April 30, 2001, AFP news report, babies exposed before birth to ethyl benzene, a toxic component in crude oil, may have a higher risk of developing congenital heart disease, US researchers announced. Another chemical used as an industrial metal degreasing agent, trichloroethylene (TCE), also boosted heart risks, said the research to be presented at the Pediatric Academic Societies annual meeting in Denver, Colorado. Congenital heart disease occurs when the heart is malformed before birth, and is the [...]

    Read more →

  • Toyota Announces New Floor Mat Interference Recall

    Once again, Toyota owners are being affected by a new recall due to floor mat interference. Presently, Toyota Motor Corp. is facing hundreds of lawsuits in the United States form vehicle owners or families who suffered personal injuries, wrongful deaths, or suffered financial losses, as a result of sticky gas pedals and floor mat interference, which may causes sudden unexpected acceleration. Since the end of 2009, Toyota has recalled nearly 4 million vehicles in the United States due to sticky [...]

    Read more →

  • Lawsuit over Seat Belts Can Proceed

    According to a recent Reuters news report, The U.S. Supreme Court ruled that federal regulations setting vehicle safety standards do not bar lawsuits seeking damages from automakers for installing lap-only seat belts. The unanimous ruling held that a California lawsuit against Mazda Motor Corp over a fatal 2002 collision involving a 1993 Mazda minivan can proceed. A passenger sitting in a rear seat and wearing a lap-only seat belt was killed. The lawsuit by the family of the passenger claimed [...]

    Read more →